

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.86647977 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 5.86647977 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.61260677 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.61260677 |
| 5 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.39891811 |
| 6 | * alpha-linolenic acid metabolic process (GO:0036109) | 5.21235571 |
| 7 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.17746357 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 5.15715231 |
| 9 | regulation of sequestering of triglyceride (GO:0010889) | 5.11079351 |
| 10 | regulation of triglyceride catabolic process (GO:0010896) | 5.05947282 |
| 11 | detection of molecule of bacterial origin (GO:0032490) | 5.05225867 |
| 12 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.00183640 |
| 13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.00183640 |
| 14 | modulation by symbiont of host immune response (GO:0052553) | 5.00183640 |
| 15 | positive regulation by symbiont of host defense response (GO:0052509) | 5.00183640 |
| 16 | modulation by symbiont of host defense response (GO:0052031) | 5.00183640 |
| 17 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.00183640 |
| 18 | complement activation, alternative pathway (GO:0006957) | 4.84867385 |
| 19 | lysine metabolic process (GO:0006553) | 4.83006396 |
| 20 | lysine catabolic process (GO:0006554) | 4.83006396 |
| 21 | fatty acid beta-oxidation (GO:0006635) | 4.81459459 |
| 22 | fatty acid transmembrane transport (GO:1902001) | 4.79778278 |
| 23 | glyoxylate metabolic process (GO:0046487) | 4.76457596 |
| 24 | response to peptidoglycan (GO:0032494) | 4.75171401 |
| 25 | low-density lipoprotein particle clearance (GO:0034383) | 4.75026143 |
| 26 | sulfur amino acid catabolic process (GO:0000098) | 4.74695020 |
| 27 | kynurenine metabolic process (GO:0070189) | 4.71210193 |
| 28 | valine metabolic process (GO:0006573) | 4.68943021 |
| 29 | plasma lipoprotein particle clearance (GO:0034381) | 4.68787785 |
| 30 | macrophage activation involved in immune response (GO:0002281) | 4.67842383 |
| 31 | bile acid biosynthetic process (GO:0006699) | 4.66601336 |
| 32 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.63187220 |
| 33 | acetyl-CoA metabolic process (GO:0006084) | 4.61291914 |
| 34 | negative regulation of interleukin-12 production (GO:0032695) | 4.57956336 |
| 35 | indole-containing compound catabolic process (GO:0042436) | 4.55032697 |
| 36 | indolalkylamine catabolic process (GO:0046218) | 4.55032697 |
| 37 | tryptophan catabolic process (GO:0006569) | 4.55032697 |
| 38 | urea metabolic process (GO:0019627) | 4.54637039 |
| 39 | urea cycle (GO:0000050) | 4.54637039 |
| 40 | negative regulation of cell killing (GO:0031342) | 4.52757813 |
| 41 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.52757813 |
| 42 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.52568580 |
| 43 | amino-acid betaine metabolic process (GO:0006577) | 4.52481583 |
| 44 | fatty acid oxidation (GO:0019395) | 4.50418734 |
| 45 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.49568370 |
| 46 | carnitine shuttle (GO:0006853) | 4.43632621 |
| 47 | lipid oxidation (GO:0034440) | 4.42428001 |
| 48 | fatty acid catabolic process (GO:0009062) | 4.40678531 |
| 49 | cysteine metabolic process (GO:0006534) | 4.37357910 |
| 50 | acylglycerol homeostasis (GO:0055090) | 4.36321079 |
| 51 | triglyceride homeostasis (GO:0070328) | 4.36321079 |
| 52 | positive regulation of lipid catabolic process (GO:0050996) | 4.31035925 |
| 53 | tryptophan metabolic process (GO:0006568) | 4.30738083 |
| 54 | biotin metabolic process (GO:0006768) | 4.27154282 |
| 55 | detection of other organism (GO:0098543) | 4.24281429 |
| 56 | regulation of protein activation cascade (GO:2000257) | 4.20360423 |
| 57 | nitrogen cycle metabolic process (GO:0071941) | 4.19819220 |
| 58 | detection of external biotic stimulus (GO:0098581) | 4.18160200 |
| 59 | 2-oxoglutarate metabolic process (GO:0006103) | 4.16621365 |
| 60 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.14117078 |
| 61 | protein carboxylation (GO:0018214) | 4.13977150 |
| 62 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.13977150 |
| 63 | positive regulation of fatty acid oxidation (GO:0046321) | 4.11986488 |
| 64 | triglyceride catabolic process (GO:0019433) | 4.11409432 |
| 65 | neutrophil activation involved in immune response (GO:0002283) | 4.09062674 |
| 66 | monocarboxylic acid catabolic process (GO:0072329) | 4.07517828 |
| 67 | negative regulation of fibrinolysis (GO:0051918) | 4.07153072 |
| 68 | cellular ketone body metabolic process (GO:0046950) | 4.04429303 |
| 69 | short-chain fatty acid metabolic process (GO:0046459) | 4.03401240 |
| 70 | high-density lipoprotein particle remodeling (GO:0034375) | 4.03244826 |
| 71 | bile acid metabolic process (GO:0008206) | 4.02141908 |
| 72 | serine family amino acid catabolic process (GO:0009071) | 4.01747236 |
| 73 | homocysteine metabolic process (GO:0050667) | 4.01171637 |
| 74 | regulation of complement activation (GO:0030449) | 3.99036875 |
| 75 | neutral lipid catabolic process (GO:0046461) | 3.98881982 |
| 76 | acylglycerol catabolic process (GO:0046464) | 3.98881982 |
| 77 | carnitine metabolic process (GO:0009437) | 3.97529142 |
| 78 | branched-chain amino acid catabolic process (GO:0009083) | 3.96662615 |
| 79 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.95139495 |
| 80 | ethanol oxidation (GO:0006069) | 3.91827951 |
| 81 | alpha-amino acid catabolic process (GO:1901606) | 3.88815558 |
| 82 | regulation of fibrinolysis (GO:0051917) | 3.87877397 |
| 83 | plasma lipoprotein particle remodeling (GO:0034369) | 3.81928423 |
| 84 | protein-lipid complex remodeling (GO:0034368) | 3.81928423 |
| 85 | macromolecular complex remodeling (GO:0034367) | 3.81928423 |
| 86 | branched-chain amino acid metabolic process (GO:0009081) | 3.79984579 |
| 87 | phospholipid homeostasis (GO:0055091) | 3.79773205 |
| 88 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.76175644 |
| 89 | detection of bacterium (GO:0016045) | 3.74076668 |
| 90 | tyrosine metabolic process (GO:0006570) | 3.73213688 |
| 91 | cellular extravasation (GO:0045123) | 3.72501295 |
| 92 | detection of biotic stimulus (GO:0009595) | 3.70393129 |
| 93 | cellular amino acid catabolic process (GO:0009063) | 3.69236734 |
| 94 | reverse cholesterol transport (GO:0043691) | 3.67640178 |
| 95 | aspartate family amino acid catabolic process (GO:0009068) | 3.67613826 |
| 96 | carnitine transmembrane transport (GO:1902603) | 3.67611530 |
| 97 | aromatic amino acid family metabolic process (GO:0009072) | 3.67508842 |
| 98 | organic acid catabolic process (GO:0016054) | 3.66851646 |
| 99 | carboxylic acid catabolic process (GO:0046395) | 3.66851646 |
| 100 | regulation of fatty acid oxidation (GO:0046320) | 3.66621255 |
| 101 | coenzyme catabolic process (GO:0009109) | 3.64178747 |
| 102 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.60688049 |
| 103 | amino-acid betaine transport (GO:0015838) | 3.57986666 |
| 104 | carnitine transport (GO:0015879) | 3.57986666 |
| 105 | regulation of cholesterol storage (GO:0010885) | 3.57104520 |
| 106 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.56787540 |
| 107 | macrophage activation (GO:0042116) | 3.55275042 |
| 108 | negative regulation of lipase activity (GO:0060192) | 3.54228866 |
| 109 | regulation of cholesterol esterification (GO:0010872) | 3.51497757 |
| 110 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.50621761 |
| 111 | microglial cell activation (GO:0001774) | 3.50031676 |
| 112 | phospholipid efflux (GO:0033700) | 3.49558050 |
| 113 | response to host immune response (GO:0052572) | 3.47203077 |
| 114 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.47203077 |
| 115 | ketone body metabolic process (GO:1902224) | 3.47010298 |
| 116 | regulation of triglyceride metabolic process (GO:0090207) | 3.46519889 |
| 117 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.46501941 |
| 118 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.46501941 |
| 119 | regulation of gamma-delta T cell activation (GO:0046643) | 3.45175767 |
| 120 | cellular response to type I interferon (GO:0071357) | 3.38511428 |
| 121 | type I interferon signaling pathway (GO:0060337) | 3.38511428 |
| 122 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.38379477 |
| 123 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.37354919 |
| 124 | response to type I interferon (GO:0034340) | 3.35170952 |
| 125 | germinal center formation (GO:0002467) | 3.34532621 |
| 126 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.33969462 |
| 127 | regulation of cholesterol metabolic process (GO:0090181) | 3.31778250 |
| 128 | cholesterol homeostasis (GO:0042632) | 3.29705163 |
| 129 | * thioester biosynthetic process (GO:0035384) | 3.29544061 |
| 130 | * acyl-CoA biosynthetic process (GO:0071616) | 3.29544061 |
| 131 | immunoglobulin mediated immune response (GO:0016064) | 3.28988250 |
| 132 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.28844472 |
| 133 | tricarboxylic acid metabolic process (GO:0072350) | 3.28196226 |
| 134 | * acyl-CoA metabolic process (GO:0006637) | 3.27875755 |
| 135 | * thioester metabolic process (GO:0035383) | 3.27875755 |
| 136 | leukocyte aggregation (GO:0070486) | 3.24856578 |
| 137 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.21813756 |
| 138 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.21733104 |
| 139 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.19759000 |
| 140 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.19159561 |
| 141 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.18345009 |
| 142 | neutrophil activation (GO:0042119) | 3.18155276 |
| 143 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.16403912 |
| 144 | response to host (GO:0075136) | 3.15715819 |
| 145 | response to host defenses (GO:0052200) | 3.15715819 |
| 146 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.15715819 |
| 147 | regulation of interferon-alpha production (GO:0032647) | 3.13972231 |
| 148 | granulocyte activation (GO:0036230) | 3.13662456 |
| 149 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.11823306 |
| 150 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.09974990 |
| 151 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.08858422 |
| 152 | positive regulation of interferon-alpha production (GO:0032727) | 3.07533631 |
| 153 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.07129091 |
| 154 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.06835780 |
| 155 | neutrophil mediated immunity (GO:0002446) | 3.06398047 |
| 156 | T-helper 1 type immune response (GO:0042088) | 3.04977017 |
| 157 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.04261016 |
| 158 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.03553345 |
| 159 | myeloid cell activation involved in immune response (GO:0002275) | 3.00579037 |
| 160 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.92971369 |
| 161 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.92618352 |
| 162 | respiratory burst (GO:0045730) | 2.88987825 |
| 163 | defense response to protozoan (GO:0042832) | 2.88601715 |
| 164 | response to muramyl dipeptide (GO:0032495) | 2.83887243 |
| 165 | positive regulation of macrophage cytokine production (GO:0060907) | 2.82148637 |
| 166 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.81837131 |
| 167 | negative regulation of T cell mediated immunity (GO:0002710) | 2.81013308 |
| 168 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.77378445 |
| 169 | regulation of mast cell degranulation (GO:0043304) | 2.73712950 |
| 170 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.71704992 |
| 171 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.71431093 |
| 172 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.70551173 |
| 173 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.66598994 |
| 174 | myeloid leukocyte mediated immunity (GO:0002444) | 2.66140588 |
| 175 | positive regulation of type 2 immune response (GO:0002830) | 2.65854693 |
| 176 | regulation of macrophage cytokine production (GO:0010935) | 2.65242269 |
| 177 | negative regulation of innate immune response (GO:0045824) | 2.64280392 |
| 178 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.63894044 |
| 179 | response to protozoan (GO:0001562) | 2.62372364 |
| 180 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.60423976 |
| 181 | neutrophil chemotaxis (GO:0030593) | 2.59492167 |
| 182 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.59129360 |
| 183 | response to interleukin-15 (GO:0070672) | 2.57994054 |
| 184 | lipid storage (GO:0019915) | 2.55783836 |
| 185 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.54441788 |
| 186 | regulation of tolerance induction (GO:0002643) | 2.54143541 |
| 187 | neutrophil migration (GO:1990266) | 2.54043094 |
| 188 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.53308533 |
| 189 | positive regulation of interferon-beta production (GO:0032728) | 2.52046722 |
| 190 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.51865967 |
| 191 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.49959780 |
| 192 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.49883331 |
| 193 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.48862176 |
| 194 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.48303197 |
| 195 | negative regulation of interleukin-6 production (GO:0032715) | 2.47629328 |
| 196 | regulation of T cell tolerance induction (GO:0002664) | 2.46811247 |
| 197 | regulation of type 2 immune response (GO:0002828) | 2.45249864 |
| 198 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.45236520 |
| 199 | myeloid leukocyte activation (GO:0002274) | 2.44544462 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.50687160 |
| 2 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 8.44032679 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.91758988 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.99689309 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.63241165 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.07374726 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.56894168 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.52972515 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.99229403 |
| 10 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.89336270 |
| 11 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.70004864 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.67710822 |
| 13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.03774075 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.97077898 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.91496451 |
| 16 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.72691145 |
| 17 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.72103687 |
| 18 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.43971677 |
| 19 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.38659253 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.38604289 |
| 21 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.30885030 |
| 22 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.13435147 |
| 23 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.04885139 |
| 24 | SPI1_23127762_ChIP-Seq_K562_Human | 2.04803012 |
| 25 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.91586972 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.91483165 |
| 27 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.90568538 |
| 28 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.85132849 |
| 29 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.82781115 |
| 30 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82542378 |
| 31 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.81253424 |
| 32 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.74306658 |
| 33 | GATA1_22025678_ChIP-Seq_K562_Human | 1.73809590 |
| 34 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.66406122 |
| 35 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.63754216 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.62382056 |
| 37 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.62040789 |
| 38 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.58931339 |
| 39 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.58483526 |
| 40 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.58221871 |
| 41 | MAF_26560356_Chip-Seq_TH1_Human | 1.58204203 |
| 42 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.54568393 |
| 43 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.52233436 |
| 44 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.50803126 |
| 45 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.48294771 |
| 46 | MYB_26560356_Chip-Seq_TH2_Human | 1.45561789 |
| 47 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.41656863 |
| 48 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.41414708 |
| 49 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.41349432 |
| 50 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39632440 |
| 51 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.37441509 |
| 52 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.37071794 |
| 53 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.36003865 |
| 54 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.32237669 |
| 55 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.31533138 |
| 56 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29670806 |
| 57 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.28755285 |
| 58 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27951245 |
| 59 | MYB_26560356_Chip-Seq_TH1_Human | 1.27748528 |
| 60 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.27729743 |
| 61 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.25897703 |
| 62 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.25240348 |
| 63 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.23397758 |
| 64 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.20613366 |
| 65 | UTX_26944678_Chip-Seq_JUKART_Human | 1.19292648 |
| 66 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.18896772 |
| 67 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16759103 |
| 68 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15812330 |
| 69 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.14166515 |
| 70 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.14087507 |
| 71 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.11908394 |
| 72 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.11770222 |
| 73 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09585037 |
| 74 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09068435 |
| 75 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08872104 |
| 76 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.08092340 |
| 77 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.06407284 |
| 78 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.06407284 |
| 79 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06149151 |
| 80 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05678021 |
| 81 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.05356603 |
| 82 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04925331 |
| 83 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.04667782 |
| 84 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03831670 |
| 85 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.02730373 |
| 86 | MAF_26560356_Chip-Seq_TH2_Human | 1.02556030 |
| 87 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.01289762 |
| 88 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.00391858 |
| 89 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.00267042 |
| 90 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.99673513 |
| 91 | GATA3_26560356_Chip-Seq_TH2_Human | 0.98916579 |
| 92 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98021782 |
| 93 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.98014958 |
| 94 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.97635913 |
| 95 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.97269030 |
| 96 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.96625316 |
| 97 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.95580395 |
| 98 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.95057152 |
| 99 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.93613351 |
| 100 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90721210 |
| 101 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.89048305 |
| 102 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87540443 |
| 103 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.84131166 |
| 104 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.84007927 |
| 105 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.84007927 |
| 106 | MYC_22102868_ChIP-Seq_BL_Human | 0.83467320 |
| 107 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.82747183 |
| 108 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.82683035 |
| 109 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.81802478 |
| 110 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.80257468 |
| 111 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.79397379 |
| 112 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.79393962 |
| 113 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.77689494 |
| 114 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.76391776 |
| 115 | GATA1_19941826_ChIP-Seq_K562_Human | 0.74350713 |
| 116 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.73638484 |
| 117 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.69959096 |
| 118 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.69633385 |
| 119 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.69555262 |
| 120 | GATA2_19941826_ChIP-Seq_K562_Human | 0.69431319 |
| 121 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.68455164 |
| 122 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.67751214 |
| 123 | * ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.66734339 |
| 124 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.64828780 |
| 125 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.64751914 |
| 126 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.63236626 |
| 127 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.62401377 |
| 128 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.62269449 |
| 129 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.61011593 |
| 130 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.60392502 |
| 131 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.59768002 |
| 132 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.58753549 |
| 133 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.57611442 |
| 134 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.56484054 |
| 135 | CBP_21632823_ChIP-Seq_H3396_Human | 0.56005985 |
| 136 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.55984742 |
| 137 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.55275180 |
| 138 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.54637400 |
| 139 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.53561651 |
| 140 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.53264435 |
| 141 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.53080017 |
| 142 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.52554295 |
| 143 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.52496241 |
| 144 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.52346103 |
| 145 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.51977923 |
| 146 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.51874783 |
| 147 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.51233697 |
| 148 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.50791897 |
| 149 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.50588860 |
| 150 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.50240743 |
| 151 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.50047995 |
| 152 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.49245803 |
| 153 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.48926377 |
| 154 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.48837959 |
| 155 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.48432949 |
| 156 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.48050904 |
| 157 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.48031063 |
| 158 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.47853522 |
| 159 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.47314122 |
| 160 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.46862422 |
| 161 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.45797376 |
| 162 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.45641312 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.58489494 |
| 2 | MP0005360_urolithiasis | 5.82525066 |
| 3 | MP0005365_abnormal_bile_salt | 5.08642819 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.89700725 |
| 5 | MP0003303_peritoneal_inflammation | 4.37836958 |
| 6 | MP0005670_abnormal_white_adipose | 3.63342404 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.62324221 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.58143770 |
| 9 | MP0003436_decreased_susceptibility_to | 3.39444828 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 3.18650542 |
| 11 | MP0003252_abnormal_bile_duct | 3.02674674 |
| 12 | MP0004130_abnormal_muscle_cell | 2.91372546 |
| 13 | MP0009785_altered_susceptibility_to | 2.91136103 |
| 14 | MP0001835_abnormal_antigen_presentation | 2.82654085 |
| 15 | MP0002837_dystrophic_cardiac_calcinosis | 2.68331945 |
| 16 | MP0002419_abnormal_innate_immunity | 2.67160447 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.58297306 |
| 18 | MP0005666_abnormal_adipose_tissue | 2.51638778 |
| 19 | MP0009840_abnormal_foam_cell | 2.49897164 |
| 20 | MP0006082_CNS_inflammation | 2.46528059 |
| 21 | MP0005332_abnormal_amino_acid | 2.46514025 |
| 22 | MP0003300_gastrointestinal_ulcer | 2.42137087 |
| 23 | MP0005083_abnormal_biliary_tract | 2.40318840 |
| 24 | MP0005025_abnormal_response_to | 2.38065032 |
| 25 | MP0002148_abnormal_hypersensitivity_rea | 2.37285800 |
| 26 | * MP0002118_abnormal_lipid_homeostasis | 2.36748745 |
| 27 | MP0005000_abnormal_immune_tolerance | 2.32649254 |
| 28 | MP0003195_calcinosis | 2.27057073 |
| 29 | MP0001790_abnormal_immune_system | 2.22347910 |
| 30 | MP0005387_immune_system_phenotype | 2.22347910 |
| 31 | MP0000609_abnormal_liver_physiology | 2.14626271 |
| 32 | MP0001800_abnormal_humoral_immune | 2.05986979 |
| 33 | MP0000685_abnormal_immune_system | 2.02828184 |
| 34 | MP0004510_myositis | 2.02825216 |
| 35 | MP0001533_abnormal_skeleton_physiology | 1.98914247 |
| 36 | MP0005671_abnormal_response_to | 1.96340228 |
| 37 | MP0001666_abnormal_nutrient_absorption | 1.96232021 |
| 38 | MP0002723_abnormal_immune_serum | 1.95646832 |
| 39 | MP0002452_abnormal_antigen_presenting | 1.90247285 |
| 40 | MP0004185_abnormal_adipocyte_glucose | 1.88774325 |
| 41 | MP0002971_abnormal_brown_adipose | 1.85726624 |
| 42 | MP0005319_abnormal_enzyme/_coenzyme | 1.85201825 |
| 43 | MP0003828_pulmonary_edema | 1.82510560 |
| 44 | MP0004947_skin_inflammation | 1.76098877 |
| 45 | MP0008260_abnormal_autophagy | 1.75509852 |
| 46 | MP0002420_abnormal_adaptive_immunity | 1.72566898 |
| 47 | MP0001819_abnormal_immune_cell | 1.71482965 |
| 48 | MP0003646_muscle_fatigue | 1.70060322 |
| 49 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.67462009 |
| 50 | MP0004019_abnormal_vitamin_homeostasis | 1.66053994 |
| 51 | MP0005375_adipose_tissue_phenotype | 1.60956480 |
| 52 | MP0001845_abnormal_inflammatory_respons | 1.58580796 |
| 53 | MP0003172_abnormal_lysosome_physiology | 1.54810856 |
| 54 | MP0003705_abnormal_hypodermis_morpholog | 1.53621977 |
| 55 | MP0003186_abnormal_redox_activity | 1.53572788 |
| 56 | MP0005464_abnormal_platelet_physiology | 1.52913333 |
| 57 | MP0001764_abnormal_homeostasis | 1.52729605 |
| 58 | MP0002405_respiratory_system_inflammati | 1.49096017 |
| 59 | MP0009278_abnormal_bone_marrow | 1.46387562 |
| 60 | MP0005164_abnormal_response_to | 1.45196830 |
| 61 | MP0005334_abnormal_fat_pad | 1.44627609 |
| 62 | MP0001545_abnormal_hematopoietic_system | 1.43654009 |
| 63 | MP0005397_hematopoietic_system_phenotyp | 1.43654009 |
| 64 | MP0000858_altered_metastatic_potential | 1.42780119 |
| 65 | MP0006036_abnormal_mitochondrial_physio | 1.41760343 |
| 66 | MP0010155_abnormal_intestine_physiology | 1.41240073 |
| 67 | MP0004883_abnormal_blood_vessel | 1.33397068 |
| 68 | MP0005535_abnormal_body_temperature | 1.33323712 |
| 69 | MP0008438_abnormal_cutaneous_collagen | 1.32186814 |
| 70 | MP0005451_abnormal_body_composition | 1.29610470 |
| 71 | MP0002998_abnormal_bone_remodeling | 1.29428517 |
| 72 | MP0005166_decreased_susceptibility_to | 1.27729758 |
| 73 | MP0009643_abnormal_urine_homeostasis | 1.27429019 |
| 74 | MP0009115_abnormal_fat_cell | 1.22802635 |
| 75 | MP0003011_delayed_dark_adaptation | 1.21738930 |
| 76 | MP0002138_abnormal_hepatobiliary_system | 1.21121818 |
| 77 | MP0008004_abnormal_stomach_pH | 1.20911726 |
| 78 | MP0000716_abnormal_immune_system | 1.20311903 |
| 79 | MP0001661_extended_life_span | 1.18336445 |
| 80 | MP0003448_altered_tumor_morphology | 1.15391048 |
| 81 | MP0005330_cardiomyopathy | 1.14964643 |
| 82 | MP0002078_abnormal_glucose_homeostasis | 1.14610182 |
| 83 | MP0003656_abnormal_erythrocyte_physiolo | 1.14491122 |
| 84 | MP0002132_abnormal_respiratory_system | 1.13535240 |
| 85 | MP0002876_abnormal_thyroid_physiology | 1.11491755 |
| 86 | MP0002398_abnormal_bone_marrow | 1.06975704 |
| 87 | MP0003868_abnormal_feces_composition | 1.05760248 |
| 88 | MP0003724_increased_susceptibility_to | 1.03608972 |
| 89 | MP0001851_eye_inflammation | 1.02954180 |
| 90 | MP0000598_abnormal_liver_morphology | 1.02816574 |
| 91 | MP0002254_reproductive_system_inflammat | 1.01660204 |
| 92 | MP0000604_amyloidosis | 1.01617670 |
| 93 | MP0009763_increased_sensitivity_to | 1.01057126 |
| 94 | MP0003690_abnormal_glial_cell | 1.00435670 |
| 95 | MP0002970_abnormal_white_adipose | 0.97910078 |
| 96 | MP0000465_gastrointestinal_hemorrhage | 0.97609440 |
| 97 | MP0003763_abnormal_thymus_physiology | 0.96665916 |
| 98 | MP0005448_abnormal_energy_balance | 0.96568809 |
| 99 | MP0003453_abnormal_keratinocyte_physiol | 0.96380863 |
| 100 | MP0005647_abnormal_sex_gland | 0.96189722 |
| 101 | MP0009764_decreased_sensitivity_to | 0.94360809 |
| 102 | MP0000689_abnormal_spleen_morphology | 0.93433385 |
| 103 | MP0008775_abnormal_heart_ventricle | 0.93072818 |
| 104 | MP0009333_abnormal_splenocyte_physiolog | 0.92974750 |
| 105 | MP0005310_abnormal_salivary_gland | 0.90197713 |
| 106 | MP0002722_abnormal_immune_system | 0.89980775 |
| 107 | MP0009697_abnormal_copulation | 0.88636009 |
| 108 | MP0002429_abnormal_blood_cell | 0.88089881 |
| 109 | MP0008469_abnormal_protein_level | 0.84771156 |
| 110 | MP0003221_abnormal_cardiomyocyte_apopto | 0.84466350 |
| 111 | MP0001544_abnormal_cardiovascular_syste | 0.83274840 |
| 112 | MP0005385_cardiovascular_system_phenoty | 0.83274840 |
| 113 | MP0000751_myopathy | 0.83226657 |
| 114 | MP0000003_abnormal_adipose_tissue | 0.83045584 |
| 115 | MP0003183_abnormal_peptide_metabolism | 0.82482775 |
| 116 | MP0004215_abnormal_myocardial_fiber | 0.82269550 |
| 117 | MP0005275_abnormal_skin_tensile | 0.82111203 |
| 118 | MP0002277_abnormal_respiratory_mucosa | 0.81619206 |
| 119 | MP0004087_abnormal_muscle_fiber | 0.81444713 |
| 120 | MP0000249_abnormal_blood_vessel | 0.81209699 |
| 121 | MP0004036_abnormal_muscle_relaxation | 0.81110147 |
| 122 | MP0009642_abnormal_blood_homeostasis | 0.80383394 |
| 123 | MP0001756_abnormal_urination | 0.80197392 |
| 124 | MP0003045_fibrosis | 0.80096353 |
| 125 | MP0001881_abnormal_mammary_gland | 0.79849360 |
| 126 | MP0005376_homeostasis/metabolism_phenot | 0.79249750 |
| 127 | MP0003091_abnormal_cell_migration | 0.78846497 |
| 128 | MP0006138_congestive_heart_failure | 0.78470811 |
| 129 | MP0004381_abnormal_hair_follicle | 0.77907512 |
| 130 | MP0005266_abnormal_metabolism | 0.76774232 |
| 131 | MP0004084_abnormal_cardiac_muscle | 0.76019324 |
| 132 | MP0010368_abnormal_lymphatic_system | 0.75707494 |
| 133 | MP0008874_decreased_physiological_sensi | 0.73816373 |
| 134 | MP0002332_abnormal_exercise_endurance | 0.73696369 |
| 135 | MP0005636_abnormal_mineral_homeostasis | 0.72872546 |
| 136 | MP0003959_abnormal_lean_body | 0.72485939 |
| 137 | MP0005390_skeleton_phenotype | 0.71510466 |
| 138 | MP0002972_abnormal_cardiac_muscle | 0.68933521 |
| 139 | MP0002269_muscular_atrophy | 0.68754796 |
| 140 | MP0006035_abnormal_mitochondrial_morpho | 0.68122380 |
| 141 | MP0000013_abnormal_adipose_tissue | 0.67579104 |
| 142 | MP0005620_abnormal_muscle_contractility | 0.67201577 |
| 143 | MP0005058_abnormal_lysosome_morphology | 0.66316538 |
| 144 | MP0010630_abnormal_cardiac_muscle | 0.63827814 |
| 145 | MP0002796_impaired_skin_barrier | 0.63477423 |
| 146 | MP0000343_altered_response_to | 0.62159081 |
| 147 | MP0000230_abnormal_systemic_arterial | 0.61248429 |
| 148 | MP0003329_amyloid_beta_deposits | 0.60849579 |
| 149 | MP0000749_muscle_degeneration | 0.59935527 |
| 150 | MP0005452_abnormal_adipose_tissue | 0.57240349 |
| 151 | MP0003953_abnormal_hormone_level | 0.55516608 |
| 152 | MP0004147_increased_porphyrin_level | 0.55087394 |
| 153 | MP0001853_heart_inflammation | 0.54934690 |
| 154 | MP0002060_abnormal_skin_morphology | 0.50890420 |
| 155 | MP0002136_abnormal_kidney_physiology | 0.50842609 |
| 156 | MP0005167_abnormal_blood-brain_barrier | 0.50300188 |
| 157 | MP0009765_abnormal_xenobiotic_induced | 0.50253582 |
| 158 | MP0003075_altered_response_to | 0.50106504 |
| 159 | MP0002168_other_aberrant_phenotype | 0.48651274 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.70656464 |
| 2 | Orchitis (HP:0100796) | 5.48155197 |
| 3 | Xanthomatosis (HP:0000991) | 5.47723168 |
| 4 | Deep venous thrombosis (HP:0002625) | 5.46036239 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 5.38511790 |
| 6 | Retrobulbar optic neuritis (HP:0100654) | 5.31847865 |
| 7 | Optic neuritis (HP:0100653) | 5.31847865 |
| 8 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.16475236 |
| 9 | Myositis (HP:0100614) | 5.15141818 |
| 10 | Recurrent bacterial skin infections (HP:0005406) | 4.95013864 |
| 11 | Hyperglycinuria (HP:0003108) | 4.92721670 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 4.91863791 |
| 13 | Recurrent abscess formation (HP:0002722) | 4.90030446 |
| 14 | Complement deficiency (HP:0004431) | 4.84619775 |
| 15 | Abnormality of macrophages (HP:0004311) | 4.67091604 |
| 16 | Hyperammonemia (HP:0001987) | 4.64132248 |
| 17 | Ketosis (HP:0001946) | 4.63593986 |
| 18 | Hypoglycemic coma (HP:0001325) | 4.56814437 |
| 19 | Abnormality of glycine metabolism (HP:0010895) | 4.56760607 |
| 20 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.56760607 |
| 21 | Prolonged partial thromboplastin time (HP:0003645) | 4.52296760 |
| 22 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.49151708 |
| 23 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.41877715 |
| 24 | Hypobetalipoproteinemia (HP:0003563) | 4.37825951 |
| 25 | Epidermoid cyst (HP:0200040) | 4.35783901 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 4.24640189 |
| 27 | Hyperglycinemia (HP:0002154) | 4.23496781 |
| 28 | Hypolipoproteinemia (HP:0010981) | 4.07091248 |
| 29 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.01346890 |
| 30 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.97592893 |
| 31 | Keratoconjunctivitis sicca (HP:0001097) | 3.95895512 |
| 32 | Stomatitis (HP:0010280) | 3.91699472 |
| 33 | Ketoacidosis (HP:0001993) | 3.89887431 |
| 34 | Mediastinal lymphadenopathy (HP:0100721) | 3.61172653 |
| 35 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.60764881 |
| 36 | Gastrointestinal infarctions (HP:0005244) | 3.60436529 |
| 37 | Keratoconjunctivitis (HP:0001096) | 3.58685863 |
| 38 | Abnormality of complement system (HP:0005339) | 3.49661902 |
| 39 | Dicarboxylic aciduria (HP:0003215) | 3.46899363 |
| 40 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.46899363 |
| 41 | Myoglobinuria (HP:0002913) | 3.45166018 |
| 42 | Joint hemorrhage (HP:0005261) | 3.44121076 |
| 43 | Hypercholesterolemia (HP:0003124) | 3.43136066 |
| 44 | Abnormality of glycolipid metabolism (HP:0010969) | 3.39422176 |
| 45 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.39422176 |
| 46 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.39422176 |
| 47 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.36008118 |
| 48 | Abnormality of the common coagulation pathway (HP:0010990) | 3.31752900 |
| 49 | Gingivitis (HP:0000230) | 3.25590569 |
| 50 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.15701184 |
| 51 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.10677555 |
| 52 | Myocardial infarction (HP:0001658) | 3.06536160 |
| 53 | Skin nodule (HP:0200036) | 3.04016723 |
| 54 | Recurrent skin infections (HP:0001581) | 3.03029025 |
| 55 | Vasculitis (HP:0002633) | 2.99249876 |
| 56 | Arterial thrombosis (HP:0004420) | 2.96291468 |
| 57 | Meningitis (HP:0001287) | 2.95236935 |
| 58 | Increased IgE level (HP:0003212) | 2.92983299 |
| 59 | Hypertriglyceridemia (HP:0002155) | 2.92972157 |
| 60 | Abnormality of methionine metabolism (HP:0010901) | 2.92714775 |
| 61 | Obstructive lung disease (HP:0006536) | 2.92531903 |
| 62 | Chronic obstructive pulmonary disease (HP:0006510) | 2.92531903 |
| 63 | Recurrent fungal infections (HP:0002841) | 2.92224001 |
| 64 | Abnormality of serum amino acid levels (HP:0003112) | 2.91683087 |
| 65 | Fat malabsorption (HP:0002630) | 2.90273034 |
| 66 | Gingival bleeding (HP:0000225) | 2.89176707 |
| 67 | Gangrene (HP:0100758) | 2.84996468 |
| 68 | Metabolic acidosis (HP:0001942) | 2.84409734 |
| 69 | Rhabdomyolysis (HP:0003201) | 2.83332170 |
| 70 | Spontaneous hematomas (HP:0007420) | 2.83050421 |
| 71 | Abnormality of the intrinsic pathway (HP:0010989) | 2.82762288 |
| 72 | Hemoptysis (HP:0002105) | 2.82060097 |
| 73 | Peritonitis (HP:0002586) | 2.81607814 |
| 74 | Abnormality of purine metabolism (HP:0004352) | 2.80112155 |
| 75 | Pulmonary infiltrates (HP:0002113) | 2.79317308 |
| 76 | Urticaria (HP:0001025) | 2.76207383 |
| 77 | Cerebral edema (HP:0002181) | 2.70311136 |
| 78 | Encephalitis (HP:0002383) | 2.70171348 |
| 79 | Lethargy (HP:0001254) | 2.70082207 |
| 80 | Pulmonary embolism (HP:0002204) | 2.68276938 |
| 81 | Generalized aminoaciduria (HP:0002909) | 2.67001486 |
| 82 | Nausea (HP:0002018) | 2.60197149 |
| 83 | Abnormality of nucleobase metabolism (HP:0010932) | 2.59952757 |
| 84 | Oligomenorrhea (HP:0000876) | 2.59634734 |
| 85 | Anorexia (HP:0002039) | 2.59353908 |
| 86 | Hyperbilirubinemia (HP:0002904) | 2.55499810 |
| 87 | Loss of speech (HP:0002371) | 2.53957463 |
| 88 | Systemic lupus erythematosus (HP:0002725) | 2.50438512 |
| 89 | Hemorrhage of the eye (HP:0011885) | 2.50352557 |
| 90 | Abnormality of proline metabolism (HP:0010907) | 2.49740018 |
| 91 | Hydroxyprolinuria (HP:0003080) | 2.49740018 |
| 92 | Episodic fever (HP:0001954) | 2.42671017 |
| 93 | Pancreatitis (HP:0001733) | 2.41286208 |
| 94 | Increased cerebral lipofuscin (HP:0011813) | 2.41034124 |
| 95 | T lymphocytopenia (HP:0005403) | 2.39849449 |
| 96 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.38838076 |
| 97 | Delayed CNS myelination (HP:0002188) | 2.38491003 |
| 98 | Cholelithiasis (HP:0001081) | 2.38102435 |
| 99 | Chest pain (HP:0100749) | 2.37305787 |
| 100 | Abnormal gallbladder morphology (HP:0012437) | 2.35943819 |
| 101 | Difficulty running (HP:0009046) | 2.35514741 |
| 102 | Vomiting (HP:0002013) | 2.34520485 |
| 103 | Hypoglycemic seizures (HP:0002173) | 2.34119581 |
| 104 | Cellulitis (HP:0100658) | 2.32820064 |
| 105 | Acanthosis nigricans (HP:0000956) | 2.32002540 |
| 106 | Increased serum ferritin (HP:0003281) | 2.31279936 |
| 107 | Conjugated hyperbilirubinemia (HP:0002908) | 2.30079538 |
| 108 | Hepatocellular carcinoma (HP:0001402) | 2.30065784 |
| 109 | Prolonged bleeding time (HP:0003010) | 2.29973256 |
| 110 | Increased muscle lipid content (HP:0009058) | 2.29069063 |
| 111 | Abnormality of T cell number (HP:0011839) | 2.27221421 |
| 112 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.26486917 |
| 113 | Dysostosis multiplex (HP:0000943) | 2.26344869 |
| 114 | Epistaxis (HP:0000421) | 2.22417534 |
| 115 | Muscle fiber splitting (HP:0003555) | 2.21860812 |
| 116 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.19633963 |
| 117 | Abnormality of the endocardium (HP:0004306) | 2.19100087 |
| 118 | Renal cortical cysts (HP:0000803) | 2.17577633 |
| 119 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.17506655 |
| 120 | Gout (HP:0001997) | 2.17148719 |
| 121 | Leukocytosis (HP:0001974) | 2.16316626 |
| 122 | Polycythemia (HP:0001901) | 2.15922175 |
| 123 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.15511857 |
| 124 | Recurrent cutaneous fungal infections (HP:0011370) | 2.15511857 |
| 125 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.15161652 |
| 126 | Purpura (HP:0000979) | 2.14161265 |
| 127 | Proximal tubulopathy (HP:0000114) | 2.13652062 |
| 128 | Abnormality of the pleura (HP:0002103) | 2.12993953 |
| 129 | Abnormal gallbladder physiology (HP:0012438) | 2.11740460 |
| 130 | Cholecystitis (HP:0001082) | 2.11740460 |
| 131 | Steatorrhea (HP:0002570) | 2.11573931 |
| 132 | Hypochromic microcytic anemia (HP:0004840) | 2.11444846 |
| 133 | Hyperglycemia (HP:0003074) | 2.11304562 |
| 134 | Disinhibition (HP:0000734) | 2.10164811 |
| 135 | Acne (HP:0001061) | 2.09420934 |
| 136 | Asymmetric septal hypertrophy (HP:0001670) | 2.08936937 |
| 137 | Exercise-induced myalgia (HP:0003738) | 2.08928098 |
| 138 | Polyneuropathy (HP:0001271) | 2.06773280 |
| 139 | Abnormality of iron homeostasis (HP:0011031) | 2.06610625 |
| 140 | Abnormal cartilage morphology (HP:0002763) | 2.05642011 |
| 141 | Hepatic necrosis (HP:0002605) | 2.05235078 |
| 142 | Vertigo (HP:0002321) | 2.05215828 |
| 143 | Thrombophlebitis (HP:0004418) | 2.04743526 |
| 144 | Abnormality of the peritoneum (HP:0002585) | 2.04276497 |
| 145 | Increased IgM level (HP:0003496) | 2.04015811 |
| 146 | Glomerulopathy (HP:0100820) | 2.02905301 |
| 147 | Vacuolated lymphocytes (HP:0001922) | 2.02881960 |
| 148 | Right ventricular cardiomyopathy (HP:0011663) | 2.02669147 |
| 149 | Vascular calcification (HP:0004934) | 2.01688303 |
| 150 | Pigmentary retinal degeneration (HP:0001146) | 2.00698338 |
| 151 | Amyloidosis (HP:0011034) | 2.00265638 |
| 152 | Brushfield spots (HP:0001088) | 1.99122506 |
| 153 | Colitis (HP:0002583) | 1.98806987 |
| 154 | Increased purine levels (HP:0004368) | 1.98084873 |
| 155 | Hyperuricemia (HP:0002149) | 1.98084873 |
| 156 | Autoimmune thrombocytopenia (HP:0001973) | 1.95540835 |
| 157 | Recurrent viral infections (HP:0004429) | 1.95450018 |
| 158 | Hepatosplenomegaly (HP:0001433) | 1.95011586 |
| 159 | Acanthocytosis (HP:0001927) | 1.93691238 |
| 160 | Slow saccadic eye movements (HP:0000514) | 1.93349899 |
| 161 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.93205679 |
| 162 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.93205679 |
| 163 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.93205679 |
| 164 | Inflammation of the large intestine (HP:0002037) | 1.92608161 |
| 165 | Hypergammaglobulinemia (HP:0010702) | 1.92574285 |
| 166 | Sensorimotor neuropathy (HP:0007141) | 1.91882681 |
| 167 | Joint swelling (HP:0001386) | 1.91540978 |
| 168 | Spontaneous abortion (HP:0005268) | 1.90761603 |
| 169 | Hypochromic anemia (HP:0001931) | 1.89595646 |
| 170 | Osteomyelitis (HP:0002754) | 1.89146890 |
| 171 | Interstitial pulmonary disease (HP:0006530) | 1.89116534 |
| 172 | Spastic diplegia (HP:0001264) | 1.89103568 |
| 173 | Esophageal varix (HP:0002040) | 1.88914714 |
| 174 | Neonatal onset (HP:0003623) | 1.88261106 |
| 175 | Cardiovascular calcification (HP:0011915) | 1.87033863 |
| 176 | Irritability (HP:0000737) | 1.87014111 |
| 177 | Glomerulonephritis (HP:0000099) | 1.86262624 |
| 178 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.85084800 |
| 179 | Mucopolysacchariduria (HP:0008155) | 1.85084800 |
| 180 | Sudden death (HP:0001699) | 1.85027291 |
| 181 | Late onset (HP:0003584) | 1.84825285 |
| 182 | Elevated hepatic transaminases (HP:0002910) | 1.83048022 |
| 183 | Hyporeflexia of lower limbs (HP:0002600) | 1.82655797 |
| 184 | Increased connective tissue (HP:0009025) | 1.79204562 |
| 185 | Abnormality of the gallbladder (HP:0005264) | 1.78801395 |
| 186 | Insulin resistance (HP:0000855) | 1.78153198 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.00104065 |
| 2 | RIPK4 | 4.05911862 |
| 3 | SIK1 | 4.05728728 |
| 4 | TRIB3 | 3.71481477 |
| 5 | PDK3 | 3.38904641 |
| 6 | PDK4 | 3.38904641 |
| 7 | ERN1 | 3.22647143 |
| 8 | CAMK1D | 3.15802273 |
| 9 | IRAK4 | 2.95917040 |
| 10 | BLK | 2.93303772 |
| 11 | FGFR4 | 2.65083028 |
| 12 | PKN2 | 2.55099263 |
| 13 | INSRR | 2.41476206 |
| 14 | PRPF4B | 2.26261851 |
| 15 | MAP4K1 | 2.20418937 |
| 16 | CAMK1G | 2.19521018 |
| 17 | PDK2 | 2.10422024 |
| 18 | ZAP70 | 1.87829452 |
| 19 | FGR | 1.85483980 |
| 20 | MST1R | 1.84191007 |
| 21 | TAOK1 | 1.79751781 |
| 22 | TTN | 1.73603587 |
| 23 | MATK | 1.67553580 |
| 24 | PRKAA2 | 1.62680895 |
| 25 | MAP3K11 | 1.55562583 |
| 26 | LMTK2 | 1.55508501 |
| 27 | FLT3 | 1.52431622 |
| 28 | RIPK1 | 1.52019567 |
| 29 | TAOK2 | 1.51828310 |
| 30 | FES | 1.49713165 |
| 31 | MAP3K1 | 1.44556500 |
| 32 | GRK7 | 1.42815822 |
| 33 | MAP3K13 | 1.41153123 |
| 34 | OBSCN | 1.37185957 |
| 35 | TNK2 | 1.35827422 |
| 36 | PINK1 | 1.35261712 |
| 37 | TXK | 1.34368682 |
| 38 | BMPR2 | 1.32977567 |
| 39 | MAPK11 | 1.28886639 |
| 40 | HCK | 1.28294774 |
| 41 | LATS1 | 1.27454346 |
| 42 | KSR2 | 1.26338054 |
| 43 | NEK9 | 1.23137645 |
| 44 | ERBB4 | 1.21909308 |
| 45 | PHKG1 | 1.19984204 |
| 46 | PHKG2 | 1.19984204 |
| 47 | JAK1 | 1.19272332 |
| 48 | SYK | 1.18841301 |
| 49 | TYK2 | 1.17765014 |
| 50 | TIE1 | 1.17246697 |
| 51 | TAOK3 | 1.15755665 |
| 52 | FGFR2 | 1.15204130 |
| 53 | BTK | 1.13635824 |
| 54 | MAP2K4 | 1.12673132 |
| 55 | MYLK | 1.12395420 |
| 56 | GRK6 | 1.10724880 |
| 57 | IKBKB | 1.10191842 |
| 58 | PIK3CA | 1.10074415 |
| 59 | FRK | 1.09665032 |
| 60 | PIK3CG | 1.09332177 |
| 61 | LYN | 1.08635426 |
| 62 | TBK1 | 1.06164686 |
| 63 | PRKAA1 | 1.03187125 |
| 64 | CDC42BPA | 1.03133775 |
| 65 | EPHB1 | 1.01628172 |
| 66 | JAK2 | 1.01280557 |
| 67 | DDR2 | 0.99877336 |
| 68 | MAP2K3 | 0.97366251 |
| 69 | PTK6 | 0.96202681 |
| 70 | PDPK1 | 0.92844920 |
| 71 | YES1 | 0.92374645 |
| 72 | FGFR3 | 0.91399829 |
| 73 | MOS | 0.90320002 |
| 74 | IRAK3 | 0.89796829 |
| 75 | MAP3K7 | 0.89688826 |
| 76 | ABL2 | 0.89176355 |
| 77 | MET | 0.82642133 |
| 78 | LCK | 0.82603067 |
| 79 | TGFBR2 | 0.82491306 |
| 80 | ICK | 0.82316351 |
| 81 | MARK2 | 0.79094528 |
| 82 | MAP3K2 | 0.79043818 |
| 83 | PDK1 | 0.75383473 |
| 84 | MAP2K6 | 0.75022206 |
| 85 | DAPK2 | 0.74121065 |
| 86 | MAPK12 | 0.73191935 |
| 87 | PRKACG | 0.72490197 |
| 88 | MARK3 | 0.71539092 |
| 89 | KDR | 0.70790733 |
| 90 | MAP3K3 | 0.70056516 |
| 91 | PDGFRA | 0.69952606 |
| 92 | WNK4 | 0.68239062 |
| 93 | CDK6 | 0.63783528 |
| 94 | STK38L | 0.59480061 |
| 95 | GSK3A | 0.57331426 |
| 96 | SIK3 | 0.56688926 |
| 97 | CSK | 0.56172809 |
| 98 | PRKD1 | 0.54846658 |
| 99 | MAPK4 | 0.53446160 |
| 100 | RET | 0.53237788 |
| 101 | CHUK | 0.52862092 |
| 102 | MAPK7 | 0.52586354 |
| 103 | SGK2 | 0.52273272 |
| 104 | MAP2K1 | 0.52092484 |
| 105 | MAP3K5 | 0.52053370 |
| 106 | LRRK2 | 0.51320898 |
| 107 | NLK | 0.50971268 |
| 108 | STK10 | 0.49426664 |
| 109 | PRKD2 | 0.48735875 |
| 110 | MAP3K10 | 0.48162763 |
| 111 | CAMKK2 | 0.47533742 |
| 112 | MTOR | 0.46916285 |
| 113 | SGK3 | 0.46869151 |
| 114 | MAP3K14 | 0.46482519 |
| 115 | PRKCZ | 0.46442634 |
| 116 | MAP3K6 | 0.46044627 |
| 117 | PKN1 | 0.45826158 |
| 118 | CSF1R | 0.45409963 |
| 119 | FYN | 0.44306260 |
| 120 | KSR1 | 0.43889978 |
| 121 | ITK | 0.43627630 |
| 122 | HIPK2 | 0.42977300 |
| 123 | IKBKE | 0.41687737 |
| 124 | PTK2B | 0.40332069 |
| 125 | IGF1R | 0.40107150 |
| 126 | RAF1 | 0.40057545 |
| 127 | TEC | 0.39579935 |
| 128 | BMX | 0.39287603 |
| 129 | EPHA3 | 0.38358593 |
| 130 | PIM1 | 0.36650703 |
| 131 | PRKCH | 0.35760305 |
| 132 | JAK3 | 0.34891113 |
| 133 | STK39 | 0.34875387 |
| 134 | NEK1 | 0.33631660 |
| 135 | RPS6KL1 | 0.33548547 |
| 136 | RPS6KC1 | 0.33548547 |
| 137 | PAK3 | 0.33336788 |
| 138 | STK38 | 0.32864783 |
| 139 | IRAK1 | 0.32465243 |
| 140 | CDK4 | 0.31991309 |
| 141 | DAPK3 | 0.31842948 |
| 142 | STK3 | 0.31663115 |
| 143 | PRKCQ | 0.30441534 |
| 144 | IRAK2 | 0.29171580 |
| 145 | CAMK2G | 0.28081631 |
| 146 | DYRK1B | 0.27414413 |
| 147 | PBK | 0.25686339 |
| 148 | ERBB2 | 0.25173941 |
| 149 | PDGFRB | 0.24561049 |
| 150 | CDK9 | 0.24219527 |
| 151 | KIT | 0.23673851 |
| 152 | CAMK4 | 0.22011830 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.59670148 |
| 2 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.25701084 |
| 3 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.14060611 |
| 4 | * Fatty acid degradation_Homo sapiens_hsa00071 | 3.12865106 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.06903476 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.86962279 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.86163608 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.82819896 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.79694690 |
| 10 | * PPAR signaling pathway_Homo sapiens_hsa03320 | 2.63712743 |
| 11 | * Fatty acid metabolism_Homo sapiens_hsa01212 | 2.63125775 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.58795220 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.53198910 |
| 14 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.52995943 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.47585101 |
| 16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.46221019 |
| 17 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.45015791 |
| 18 | Malaria_Homo sapiens_hsa05144 | 2.28744334 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.27138434 |
| 20 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.20421388 |
| 21 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.17539075 |
| 22 | * Peroxisome_Homo sapiens_hsa04146 | 2.10943746 |
| 23 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.10728987 |
| 24 | Tuberculosis_Homo sapiens_hsa05152 | 2.07036282 |
| 25 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.03381361 |
| 26 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.97920372 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.96963418 |
| 28 | Legionellosis_Homo sapiens_hsa05134 | 1.92743340 |
| 29 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.81516920 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.81228614 |
| 31 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.77884139 |
| 32 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.75166335 |
| 33 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.74081162 |
| 34 | Carbon metabolism_Homo sapiens_hsa01200 | 1.74012912 |
| 35 | Pertussis_Homo sapiens_hsa05133 | 1.73464904 |
| 36 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.73219704 |
| 37 | Allograft rejection_Homo sapiens_hsa05330 | 1.68942844 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.68490307 |
| 39 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.67432628 |
| 40 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.66919977 |
| 41 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.64628439 |
| 42 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.58880494 |
| 43 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.58461567 |
| 44 | Influenza A_Homo sapiens_hsa05164 | 1.53791512 |
| 45 | Measles_Homo sapiens_hsa05162 | 1.50626434 |
| 46 | Other glycan degradation_Homo sapiens_hsa00511 | 1.49671499 |
| 47 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.47758355 |
| 48 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.46500085 |
| 49 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.45785573 |
| 50 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.45637521 |
| 51 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.45327341 |
| 52 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.44665292 |
| 53 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.44426555 |
| 54 | Histidine metabolism_Homo sapiens_hsa00340 | 1.42417842 |
| 55 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.40530851 |
| 56 | * Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.38651034 |
| 57 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.37790692 |
| 58 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.36645741 |
| 59 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.36370880 |
| 60 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.35824303 |
| 61 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.30937050 |
| 62 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.30794087 |
| 63 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.30733842 |
| 64 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.30430865 |
| 65 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.29883555 |
| 66 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.28668771 |
| 67 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.27374743 |
| 68 | Retinol metabolism_Homo sapiens_hsa00830 | 1.27036425 |
| 69 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26907676 |
| 70 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.24575467 |
| 71 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.24139559 |
| 72 | Phagosome_Homo sapiens_hsa04145 | 1.21992830 |
| 73 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.21540153 |
| 74 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19532097 |
| 75 | Bile secretion_Homo sapiens_hsa04976 | 1.18306800 |
| 76 | Lysosome_Homo sapiens_hsa04142 | 1.17639383 |
| 77 | Salmonella infection_Homo sapiens_hsa05132 | 1.17506043 |
| 78 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.16725502 |
| 79 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.16705524 |
| 80 | ABC transporters_Homo sapiens_hsa02010 | 1.14430525 |
| 81 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.12037849 |
| 82 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.09632318 |
| 83 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.98995612 |
| 84 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.98987041 |
| 85 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.96735895 |
| 86 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.95900880 |
| 87 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.95700531 |
| 88 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.94093363 |
| 89 | Asthma_Homo sapiens_hsa05310 | 0.93433839 |
| 90 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.93425207 |
| 91 | Viral myocarditis_Homo sapiens_hsa05416 | 0.92531515 |
| 92 | Hepatitis B_Homo sapiens_hsa05161 | 0.92376691 |
| 93 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.90880267 |
| 94 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.90270753 |
| 95 | Lysine degradation_Homo sapiens_hsa00310 | 0.88312789 |
| 96 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.88103284 |
| 97 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85981167 |
| 98 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.85298488 |
| 99 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.83340272 |
| 100 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.82690735 |
| 101 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.79267574 |
| 102 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.77412481 |
| 103 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.76118829 |
| 104 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.75968446 |
| 105 | * Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.75964118 |
| 106 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.75908673 |
| 107 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.74394994 |
| 108 | Sulfur relay system_Homo sapiens_hsa04122 | 0.73746415 |
| 109 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.73136609 |
| 110 | Platelet activation_Homo sapiens_hsa04611 | 0.70935830 |
| 111 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.70319038 |
| 112 | Apoptosis_Homo sapiens_hsa04210 | 0.69234592 |
| 113 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.68989635 |
| 114 | Shigellosis_Homo sapiens_hsa05131 | 0.66403712 |
| 115 | Insulin resistance_Homo sapiens_hsa04931 | 0.65572378 |
| 116 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.65326562 |
| 117 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.65178478 |
| 118 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.63391192 |
| 119 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.59780225 |
| 120 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59633253 |
| 121 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.59532007 |
| 122 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.59280855 |
| 123 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.58723723 |
| 124 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.55237173 |
| 125 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.54736714 |
| 126 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51613995 |
| 127 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.51565566 |
| 128 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49184703 |
| 129 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.48792390 |
| 130 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.46903106 |
| 131 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44962897 |
| 132 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.44434659 |
| 133 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.43536477 |
| 134 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.43495381 |
| 135 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.42317783 |
| 136 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41266657 |
| 137 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.39288475 |
| 138 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38264377 |
| 139 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.37727694 |
| 140 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37269064 |
| 141 | Galactose metabolism_Homo sapiens_hsa00052 | 0.36906653 |
| 142 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.33846115 |
| 143 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.32183529 |
| 144 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.31127231 |
| 145 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.29889563 |
| 146 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.22204827 |
| 147 | Prion diseases_Homo sapiens_hsa05020 | 0.21173020 |
| 148 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.10126701 |
| 149 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.07895582 |
| 150 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.07091089 |
| 151 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.04456545 |
| 152 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.02732379 |
| 153 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.02688370 |
| 154 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | -0.1407667 |
| 155 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | -0.1402707 |
| 156 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1388315 |
| 157 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1353984 |
| 158 | Hepatitis C_Homo sapiens_hsa05160 | -0.1209071 |
| 159 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1185230 |
| 160 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1175161 |
| 161 | Cardiac muscle contraction_Homo sapiens_hsa04260 | -0.0888745 |
| 162 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0849985 |
| 163 | Alzheimers disease_Homo sapiens_hsa05010 | -0.0791486 |
| 164 | Parkinsons disease_Homo sapiens_hsa05012 | -0.0692592 |
| 165 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0626485 |
| 166 | Amoebiasis_Homo sapiens_hsa05146 | -0.0502629 |
| 167 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.0336795 |

